Neuroendocrine Tumor (NET) Management with Dr. Pamela Kunz - Treatment Algorithm
From Oncology Brothers: Practice-Changing Cancer Discussions · · 22 min
This plays from the publisher's own server. We do not host a copy.
Description
Welcome to the Oncology Brothers podcast! In this episode, we dived deep into the complex world of neuroendocrine tumors (NETs) with renowned specialist Dr. Pamela Kunz, from Yale School of Medicine.
Join us as we explore:
- The heterogeneous nature of neuroendocrine tumors, including differences in grade, origin, and functionality
- Diagnostic workups and the role of imaging, including the use of ⁶⁸Ga-DOTATATE positron emission tomography (PET) scans
- Treatment algorithms for both localized and metastatic NETs, focusing on somatostatin analogs, ¹⁷⁷Lu-DOTATATE, and other therapeutic options
- The importance of shared decision-making in treatment approaches, especially for asymptomatic patients
- Monitoring strategies and the evolving role of biomarkers like chromogranin A
- Insights into high-grade neuroendocrine tumors and the potential for immunotherapy
Whether you're a healthcare professional or simply interested in oncology, this episode provides valuable insights into the current treatment landscape for neuroendocrine tumors.
Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o
Follow us on social media:
• X/Twitter: https://x.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!
#NeuroendocrineTumors, #NETs, #DOTATATE, #OncologyBrothers
Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem